News
VRXAW
0.0881
+6.53%
0.0054
Weekly Report: what happened at VRXA last week (0803-0807)?
Weekly Report · 5d ago
VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies 
TipRanks · 08/06 17:00
Weekly Report: what happened at VRXA last week (0727-0731)?
Weekly Report · 08/03 10:33
Veraxa Biotech Files Prospectus Related To The Resale Of Up To 25M Ordinary Shares By The Selling Shareholder
Benzinga · 07/31 21:17
VERAXA Biotech (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform
TipRanks · 07/30 17:30
VERAXA Biotech (NASDAQ: VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms
TipRanks · 07/29 17:00
VERAXA Biotech (NASDAQ: VRXA) Shareholders Approve Corporate Governance, Financing Measures 
TipRanks · 07/28 17:00
VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration
TipRanks · 07/27 18:30
Veraxa Biotech advances VXA-222 following milestone in OmniAb pact
TipRanks · 07/27 11:20
VERAXA Biotech Advances Bispecific ADC VXA‑222 With OmniAb Milestone, Moving Alliance Into Next Phase Of Cancer Therapy Discovery
Benzinga · 07/27 11:07
Weekly Report: what happened at VRXA last week (0720-0724)?
Weekly Report · 07/27 10:38
VERAXA Biotech AG (NASDAQ: VRXA) Appoints Christoph Erkel as Chief Scientific Officer
TipRanks · 07/24 17:00
VERAXA Biotech (NASDAQ: VRXA) Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany
TipRanks · 07/23 16:30
VERAXA Biotech (NASDAQ: VRXA) Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
TipRanks · 07/20 17:00
VERAXA Gets German Regulatory Feedback On Cancer Therapy Plan
Benzinga · 07/20 11:09
Weekly Report: what happened at VRXA last week (0713-0717)?
Weekly Report · 07/20 10:34
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
Barchart · 07/20 06:00
Why VERAXA Biotech (NASDAQ: VRXA) Could Benefit More Than Others From AI’s Growing Impact on Drug R&D 
TipRanks · 07/15 17:30
VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development
TipRanks · 07/13 17:30
Veraxa Biotech announces BiTAC pipeline collaboration with Ardigen
TipRanks · 07/13 11:25
More
Webull provides a variety of real-time VRXAW stock news. You can receive the latest news about Veraxa Biotech AG through multiple platforms. This information may help you make smarter investment decisions.